BACKGROUND: We hypothesized that human perivascular and subcutaneous adipose tissues hold distinct phenotypic signatures. We also evaluated the impact of clinical parameters on the adipose phenotype. Our overall goal is to understand the determinants of adipose biology so that this tissue can be manipulated therapeutically to lessen peripheral vascular disease.
Although historically viewed as a relatively inert tissue limited to roles in thermoregulation, musculoskeletal protection, and energy storage, adipose tissue is increasingly recognized as a highly active tissue with endocrine and immune functions. 1, 2 Adipose localizes focally throughout the body, and it can be grouped into the following distinct gross anatomic depots: visceral, subcutaneous, and perivascular. 3, 4, 5, 6 Although visceral adipose tissue with its relationship to ''central obesity'' has been implicated as a highly metabolically active compartment, perivascular adipose tissue also has become increasingly important under the ''outside-in'' hypotheses of vascular disease. 4, 6 Surrounding systemic vessels with the exception of the cerebral circulation, perivascular adipose tissue exhibits emerging links to Supported by the National Heart, Lung, and Blood Institute R01HL079135, 1R01HL079135-06S1, T32HL007734, American Heart Association 12GRNT9510001, and the Carl and Ruth Shapiro Family Foundation.
The authors declare no conflict of interest.vascular pathologies. 3, 4, 6, 7, 8 To date, few direct interrogations of human perivascular adipose tissue have been completed, 9, 10 and often adipose knowledge is founded on animal models or serum biomarkers coupled with imaging.
Our overall goal is to understand the determinants of adipose biology so that this tissue can be manipulated therapeutically to lessen vascular disease. In view of their theorized biologic roles, we hypothesized that perivascular and subcutaneous adipose tissue hold distinct phenotypic signatures. To test this hypothesis, appropriate institutional review board approvals were obtained for live tissue harvest in the operating room from patients undergoing below-and above-knee lowerextremity amputations performed for unreconstructable chronic (all more than 1 month) critical limb ischemia or an unsalvageable foot, and we assayed key biologic mediators representing inflammatory signaling networks. Immediately after amputation, fresh adipose was collected by surgeons from both the subcutaneous and perivascular (peritibial or popliteal artery) locations, flash frozen in liquid nitrogen, and stored at 280 C. To avoid the confounding influence of profound ischemia, we used adipose from the more proximal portions of the specimens at a level that was judged as likely to heal by the attending surgeon. A portion of these patients were also examined in a separate report.
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Protein extraction was performed with a detergent-free solution. Briefly, adipose was disrupted and homogenized in ice-cold phosphate-buffered saline with protease inhibitors. The homogenate was centrifuged (2,000g, 5 minutes at room temperature), the top fat layer was discarded, and then the supernatant was centrifuged again (10,000g, 10 minutes at 4 C). The supernatants containing the soluble proteins were finally collected for subsequent assays. The total protein concentration was determined via a Bradford protein assay.
Selected adipokines and adipose-derived hormones (ie, interleukin [IL]-6, IL-8, leptin, tumor necrosis factor-a [TNF-a], monocyte chemoattractant protein-1 (MCP-1), adiponectin, resistin, and plasminogen activator inhibitor-1 (PAI-1)) were quantified using a microparticle bead assay (Luminex Corporation, Austin, TX), and concentrations were normalized to the total protein. IL-6, IL-8, leptin, TNF-a, MCP-1, resistin, and PAI-1 are generally associated with a proinflammatory state. Adiponectin is a solely adipose-derived hormone that protects against diabetes, obesity, and atherosclerosis. Distinct corresponding tissue sections were processed via formalin fixation and paraffin embedding, and histologic analysis was performed.
Univariate comparisons for equality of means were performed with paired t tests to compare adipocyte-related mediator expression between the 2 adipose depots in each patient. Beyond comparisons between the subcutaneous and perivascular samples, we also evaluated the impact of standard clinical parameters on the adipose phenotype. Multivariate linear regression analysis was used to associate clinical factors with mediator levels.
As is typical of major amputation patients, the results showed that this sample represented a medically ill patient population (N 5 27, Table 1 ). Histologically, there were minimal differences between the perivascular and subcutaneous adipose tissue samples; both showed scattered fat necrosis and minimal chronic inflammation (Fig. 1A and B) . In comparison with subcutaneous adipose tissue, perivascular adipose tissue displayed a generally less inflamed phenotype, with statistically significant less leptin, TNF-a, MCP-1, and adiponectin (Fig. 1C ). There were also trends for less IL-6 and IL-8 in perivascular adipose tissue.
Multiple linear regression analysis did not identify any clinical predictors of the phenotype for subcutaneous adipose including body mass index. Age positively correlated with perivascular PAI-1 expression (b 5 .64, P 5 .042), and a history of hyperlipidemia was negatively associated with perivascular adipose adiponectin (b 5 21.18, P 5 .039).
Perivascular adipose tissue holds particular relevance to vascular biology in view of its tissue mass, anatomic proximity, and emerging signaling role in inflammation and vascular pathologies. 3, 4, 6, 7 Our results defined specific human phenotypic signatures in an amputation patient cohort, with the perivascular adipose tissue displaying relatively less inflammation (less adiposopathy 1 ) in totality. Adipokines and adipose-derived hormones are implicated in obesity, diabetes, and cardiovascular disease.
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The relative disparity between subcutaneous and perivascular adipose tissue expression of the adipose-derived hormones and adipokines highlights the heterogeneity of ACE 5 angiotensin-converting enzyme; ARB 5 angiotensin receptor blocker; BMI 5 body mass index; HMG-CoA 5 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor; SEM 5 standard error of the mean.
body fat depots. Proximity may allow paracrine signaling mechanisms with the popliteal and tibial arteries from which the tissues were obtained, but it is unknown if the relatively less inflamed perivascular phenotype was a primary driver of a homeostatic response to the vascular disease in this cohort or in fact secondary to vascular disease.
Notably, clinical factors (including body mass index) did not predict the adipose phenotype with 2 exceptions: age in the case of PAI-1 and hyperlipidemia in the case of adiponectin in perivascular adipose tissue. Prior research has focused on imaging and serum levels of these mediators, which may not well reflect the quality of human adipose tissue itself.
Limitations are acknowledged. Certainly, comparisons with normal, surgically sampled human adipose tissue would add great power, but such tissues (especially perivascular) are not readily available. The sample size was relatively small, and some of the mediators exhibited high variability (eg, IL-8). We highlight relative protein levels but cannot make claims about biologic activity. The cellular origin of the assayed proteins is not delineated nor is the balance of synthesis/degradation, but the results do paint a general picture of the overall tissue phenotype. Our dataset does not have visceral adipose or serum for relative comparisons; however, these have been widely described in the literature. Finally, the findings in this medically ill cohort may not apply across all patient types, but this distinct subset presents a highly clinically relevant group.
In summary, although some biologic similarity was found between subcutaneous and perivascular adipose tissues, the differential exhibited within individual patients in adipokines and adipose-derived mediators supports the concept that these tissue compartments hold distinct biologic roles. Research strategies leveraging investigative opportunities in unfortunate clinical circumstances such as major amputation may move health care toward limb loss prevention and beyond. 
